FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans Wolf

Research Profile

Living Beings

Concepts & Ideas

Molecular Sequence Data

Chemicals & Drugs

Anatomy

Physiology

Genes & Molecular Sequences

Co-author Network

Publications

TOP 3
Kalman Szenthe; Hans Wolf; Katalin Nagy; Hans Helmut Niller; Daniel Salamon; Ferenc Banati; Zoltan Bathori; Jozsef Burgyan; Anita Koroknai; Rita Lozsa; Janos Minarovits
The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Hans Helmut Niller; Hans Wolf; Janos Minarovits
Viral hit and run-oncogenesis: genetic and epigenetic scenarios.
Simon M Agwale; Joseph Forbi; Frank Notka; Ralf Wagner; Jens Wild; Terri Wrin; Hans Wolf
Broad antibody mediated cross-neutralization and preclinical immunogenicity of new codon-optimized HIV-1 clade CRF02_AG and G primary isolates.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans Wolf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kalman Szenthe; Hans Wolf; Katalin Nagy; Hans Helmut Niller; Daniel Salamon; Ferenc Banati; Zoltan Bathori; Jozsef Burgyan; Anita Koroknai; Rita Lozsa; Janos Minarovits
The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Biochemical and biophysical research communications 2013;433(4):489-95.
2011: Hans Helmut Niller; Hans Wolf; Janos Minarovits
Viral hit and run-oncogenesis: genetic and epigenetic scenarios.
Cancer letters 2011;305(2):200-17.
2011: Simon M Agwale; Joseph Forbi; Frank Notka; Ralf Wagner; Jens Wild; Terri Wrin; Hans Wolf
Broad antibody mediated cross-neutralization and preclinical immunogenicity of new codon-optimized HIV-1 clade CRF02_AG and G primary isolates.
PloS one 2011;6(8):e23233.
2011: Hans Helmut Niller; Hans Wolf; Eva Ay; Janos Minarovits
Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease.
Advances in experimental medicine and biology 2011;711():82-102.
2009: Jürgen J Wenzel; Heiko Walch; Markus Bollwein; Hans Helmut Niller; W Ankenbauer; Ralf Mauritz; Hans-Joachim Höltke; Héctor Manuel Zepeda; Hans Wolf; Wolfgang Jilg; Udo Reischl
Library of prefabricated locked nucleic acid hydrolysis probes facilitates rapid development of reverse-transcription quantitative real-time PCR assays for detection of novel influenza A/H1N1/09 virus.
Clinical chemistry 2009;55(12):2218-22.
2009: Monika Kern; Stephan Böhm; Ludwig Deml; Hans Wolf; Udo Reischl; Hans Helmut Niller
Inhibition of Legionella pneumophila PCR in respiratory samples: a quantitative approach.
Journal of microbiological methods 2009;79(2):189-93.
2009: Jens Wild; Kurt Bieler; Josef Köstler; Marie-Joelle Frachette; Simon Jeffs; Sueli Vieira; Mariano Esteban; Peter Liljeström; Guiseppe Pantaleo; Hans Wolf; Ralf Wagner
Preclinical evaluation of the immunogenicity of C-type HIV-1-based DNA and NYVAC vaccines in the Balb/C mouse model.
Viral immunology 2009;22(5):309-19.
2009: Hans Helmut Niller; Hans Wolf; Janos Minarovits
Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
Seminars in cancer biology 2009;19(3):158-64.
2009: Holger Melzl; Jürgen J Wenzel; B Kochanowski; K Feierabend; B Kreuzpaintner; E Kreuzpaintner; A Rohrhofer; S Schreder-Meindl; H Wollner; Bernd Salzberger; Udo Reischl; Wolfgang Jilg; Hans Wolf; Hans Helmut Niller
First sequence-confirmed case of infection with the new influenza A(H1N1) strain in Germany.
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2009;14(18):.
2009: Daniel Salamon; Ferenc Banati; Anita Koroknai; Mate Ravasz; Kalman Szenthe; Zoltan Bathori; Agnes Bakos; Hans Helmut Niller; Hans Wolf; Janos Minarovits
Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity.
The Journal of general virology 2009;90(Pt 5):1183-9.
2009: Petra Lindner; Ramona Molz; Erwin Yacoub-George; Hans Wolf
Rapid chemiluminescence biosensing of microcystin-LR.
Analytica chimica acta 2009;636(2):218-23.
2009: Maria Takacs; Judit Segesdi; Ferenc Banati; Anita Koroknai; Hans Wolf; Hans Helmut Niller; Janos Minarovits
The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas.
Mediterranean journal of hematology and infectious diseases 2009;1(2):e2009012.
2008: sascha Barabas; Regina Gary; Tanja Bauer; Juha Lindner; Petra Lindner; Birgit Weinberger; Wolfgang Jilg; Hans Wolf; Ludwig Deml
Urea-mediated cross-presentation of soluble Epstein-Barr virus BZLF1 protein.
PLoS pathogens 2008;4(11):e1000198.
2008: György Fejer; Anita Koroknai; Ferenc Banati; Ildiko Györy; Daniel Salamon; Hans Wolf; Hans Helmut Niller; Janos Minarovits
Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus.
The Journal of general virology 2008;89(Pt 6):1364-70.
2008: Hans Helmut Niller; Hans Wolf; Janos Minarovits
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Autoimmunity 2008;41(4):298-328.
2008: Christian Lehmann; Hans Wolf; Jianguo Xu; Quanbi Zhao; Yiming Shao; Manfred Motz; Petra Lindner
A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses.
Diagnostic microbiology and infectious disease 2008;61(1):40-8.
2008: Ferenc Banati; Anita Koroknai; Daniel Salamon; Maria Takacs; Susanna Minarovits-Kormuta; Hans Wolf; Hans Helmut Niller; Janos Minarovits
CpG-methylation silences the activity of the RNA polymerase III transcribed EBER-1 promoter of Epstein-Barr virus.
FEBS letters 2008;582(5):705-9.
2007: Borbala Gerle; Anita Koroknai; György Fejer; Agnes Bakos; Ferenc Banati; Kalman Szenthe; Hans Wolf; Hans Helmut Niller; Janos Minarovits; Daniel Salamon
Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells.
Journal of virology 2007;81(23):13242-7.
2007: Agnes Bakos; Ferenc Banati; Anita Koroknai; Maria Takacs; Daniel Salamon; Susanna Minarovits-Kormuta; Fritz Schwarzmann; Hans Wolf; Hans Helmut Niller; Janos Minarovits
High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
Virus genes 2007;35(2):195-202.
2005: Karin Stadtherr; Hans Wolf; Petra Lindner
An aptamer-based protein biochip.
Analytical chemistry 2005;77(11):3437-43.
2005: Ludwig Deml; Cornelia Speth; Manfred P Dierich; Hans Wolf; Ralf Wagner
Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses.
Molecular immunology 2005;42(2):259-77.
2004: Hans Helmut Niller; Daniel Salamon; Ferenc Banati; Fritz Schwarzmann; Hans Wolf; Janos Minarovits
The LCR of EBV makes Burkitt's lymphoma endemic.
Trends in microbiology 2004;12(11):495-9.
2004: Julia Kzhyshkowska; Elisabeth Kremmer; Markus Hofmann; Hans Wolf; Thomas Dobner
Protein arginine methylation during lytic adenovirus infection.
The Biochemical journal 2004;383(Pt 2):259-65.
2004: Udo Reischl; Mohammad T Youssef; Hans Wolf; Eija Hyytia-Trees; Nancy A Strockbine
Real-time fluorescence PCR assays for detection and characterization of heat-labile I and heat-stable I enterotoxin genes from enterotoxigenic Escherichia coli.
Journal of clinical microbiology 2004;42(9):4092-100.
2004: Hans Helmut Niller; Daniel Salamon; S Rahmann; Karin Ilg; Anita Koroknai; F Bánáti; Fritz Schwarzmann; Hans Wolf; J Minárovits
A 30 kb region of the Epstein-Barr virus genome is colinear with the rearranged human immunoglobulin gene loci: implications for a "ping-pong evolution" model for persisting viruses and their hosts. A review.
Acta microbiologica et immunologica Hungarica 2004;51(4):469-84.
2004: Hans Helmut Niller; Daniel Salamon; Karin Ilg; Anita Koroknai; Ferenc Banati; Fritz Schwarzmann; Hans Wolf; Janos Minarovits
EBV-associated neoplasms: alternative pathogenetic pathways.
Medical hypotheses 2004;62(3):387-91.
2004: Uwe Schaible; Michael Liss; Elke Prohaska; Jochen Decker; Karin Stadtherr; Hans Wolf
Affinity measurements of biological molecules by a quartz crystal microbalance (QCM) biosensor.
Methods in molecular medicine 2004;94():321-30.
2003: Daniel Salamon; Maria Takacs; Fritz Schwarzmann; Hans Wolf; Janos Minarovits; Hans Helmut Niller
High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes.
Virus genes 2003;27(1):57-66.
2003: Cornelia Thomas; Arnd Dankesreiter; Hans Wolf; Fritz Schwarzmann
The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latency.
The Journal of general virology 2003;84(Pt 4):959-64.
2003: Alexander Kofman; Marcus Graf; Ludwig Deml; Alexandra Kharazova; Hans Wolf; Ralf Wagner
Co-influence of transgene expression in mammalian cells. Mutual influence of transgenes on their expression in mammalian cells.
Tsitologiia 2003;45(4):387-91.
2003: Alexander Kofman; Marcus Graf; Ludwig Deml; Hans Wolf; Ralf Wagner
Codon usage-mediated inhibition of HIV-1 gag expression in mammalian cells occurs independently of translation.
Tsitologiia 2003;45(1):94-100.
2003: Alexander Kofman; Marcus Graf; Alexandra Bojak; Ludwig Deml; Kurt Bieler; Alexandra Kharazova; Hans Wolf; Ralf Wagner
HIV-1 gag expression is quantitatively dependent on the ratio of native and optimized codons.
Tsitologiia 2003;45(1):86-93.
2003: Hans Helmut Niller; Daniel Salamon; Karin Ilg; Anita Koroknai; Ferenc Banati; Gerald Bauml; Ovidiu Rucker; Fritz Schwarzmann; Hans Wolf; Janos Minarovits
The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
Medical science monitor : international medical journal of experimental and clinical research 2003;9(1):HY1-9.
2002: Michael Liss; Birgit Petersen; Hans Wolf; Elke Prohaska
An aptamer-based quartz crystal protein biosensor.
Analytical chemistry 2002;74(17):4488-95.
2002: Alexandra Bojak; Jens Wild; Hans Wolf; Ralf Wagner
Efficiency of a myogenic DNA vaccine is strictly dependent upon cellular localization of HIV-1 Pr55(gag).
Vaccine 2002;20(15):1980-4.
2002: Alexandra Bojak; Diana Hammer; Hans Wolf; Ralf Wagner
Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysis.
Vaccine 2002;20(15):1975-9.
2002: Hans Helmut Niller; Daniel Salamon; Jörg Uhlig; Stefanie Ranf; Marcus Granz; Fritz Schwarzmann; Hans Wolf; Janos Minarovits
Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes.
Journal of virology 2002;76(8):4113-8.
2001: Ludwig Deml; Alexandra Bojak; S Steck; Marcus Graf; Jens Wild; Reinhold Schirmbeck; Hans Wolf; Ralf Wagner
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.
Journal of virology 2001;75(22):10991-1001.
2001: Hans Helmut Niller; Daniel Salamon; Maria Takacs; Jörg Uhlig; Hans Wolf; Janos Minarovits
Protein-DNA interaction and CpG methylation at rep*/vIL-10p of latent Epstein-Barr virus genomes in lymphoid cell lines.
Biological chemistry 2001;382(10):1411-9.
2001: Thomas Dobner; D Büchner; T Zeller; Hans Wolf; Hans Helmut Niller
Specific nucleoprotein complexes within adenovirus capsids.
Biological chemistry 2001;382(9):1373-7.
2001: Julia Kzhyshkowska; H Schütt; Michael Liss; Elisabeth Kremmer; R Stauber; Hans Wolf; Thomas Dobner
Heterogeneous nuclear ribonucleoprotein E1B-AP5 is methylated in its Arg-Gly-Gly (RGG) box and interacts with human arginine methyltransferase HRMT1L1.
The Biochemical journal 2001;358(Pt 2):305-14.
2001: Nina Babel; Fritz Schwarzmann; NS Prang; M Jaeger; Hans Wolf; Florian Kern; Hans-Dieter Volk; Petra Reinke
Association between Epstein-Barr virus infection and late acute transplant rejection in long-term transplant patients.
Transplantation 2001;72(4):736-9.
2001: Ulla Raab; B Bauer; A Gigler; Karin Beckenlehner; Hans Wolf; Susanne Modrow
Cellular transcription factors that interact with p6 promoter elements of parvovirus B19.
The Journal of general virology 2001;82(Pt 6):1473-80.
2001: Maria Takacs; Daniel Salamon; S Myöhänen; H Li; Judit Segesdi; D Ujvari; Jörg Uhlig; Hans Helmut Niller; Hans Wolf; György Berencsi; Janos Minarovits
Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes.
Biological chemistry 2001;382(4):699-705.
2001: Michael Nevels; B Täuber; Thilo Spruss; Hans Wolf; Thomas Dobner
"Hit-and-run" transformation by adenovirus oncogenes.
Journal of virology 2001;75(7):3089-94.
2001: Daniel Salamon; Maria Takacs; D Ujvari; Jörg Uhlig; Hans Wolf; Janos Minarovits; Hans Helmut Niller
Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.
Journal of virology 2001;75(6):2584-96.
2001: Simone Dorsch; Bärbel Kaufmann; U Schaible; Elke Prohaska; Hans Wolf; Susanne Modrow
The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability.
The Journal of general virology 2001;82(Pt 1):191-9.
2000: L Su; Marcus Graf; Y Zhang; Hagen von Briesen; H Xing; J Köstler; Holger Melzl; Hans Wolf; Y Shao; Ralf Wagner
Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China.
Journal of virology 2000;74(23):11367-76.
2000: Ralf Wagner; Marcus Graf; Kurt Bieler; Hans Wolf; T Grunwald; P Foley; K Uberla
Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
Human gene therapy 2000;11(17):2403-13.
2000: Marcus Graf; Alexandra Bojak; Ludwig Deml; Kurt Bieler; Hans Wolf; Ralf Wagner
Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression.
Journal of virology 2000;74(22):10822-6.
2000: Michael Nevels; S Rubenwolf; Thilo Spruss; Hans Wolf; Thomas Dobner
Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein.
Journal of virology 2000;74(11):5168-81.
2000: T Fitzon; Bernd Leschonsky; Kurt Bieler; Christina Paulus; J Schröder; Hans Wolf; Ralf Wagner
Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
Virology 2000;268(2):294-307.
2000: Jochen Decker; Klaus M Weinberger; Elke Prohaska; S Hauck; C Kösslinger; Hans Wolf; A Hengerer
Characterization of a human pancreatic secretory trypsin inhibitor mutant binding to Legionella pneumophila as determined by a quartz crystal microbalance.
Journal of immunological methods 2000;233(1-2):159-65.
2000: A Hemauer; A Gigler; Karen Searle; Karin Beckenlehner; Ulla Raab; K Broliden; Hans Wolf; Georg Enders; Susanne Modrow
Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.
Journal of medical virology 2000;60(1):48-55.
1999: NS Prang; Hans Wolf; Fritz Schwarzmann
Latency of Epstein-Barr virus is stabilized by antisense-mediated control of the viral immediate-early gene BZLF-1.
Journal of medical virology 1999;59(4):512-9.
1999: G Benninger-Döring; S Pepperl; Ludwig Deml; Susanne Modrow; Hans Wolf; Wolfgang Jilg
Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
Virology 1999;264(2):289-97.
1999: A Hemauer; Karin Beckenlehner; Hans Wolf; B Lang; Susanne Modrow
Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 1999;14(1):73-7.
1999: Fritz Schwarzmann; R von Baehr; M Jäger; NS Prang; S Böhm; U Reischl; Hans Wolf; W P Bieger
A case of severe chronic active infection with Epstein-Barr virus: immunologic deficiencies associated with a lytic virus strain.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(3):626-31.
1999: Frank Notka; C Stahl-Hennig; U Dittmer; Hans Wolf; Ralf Wagner
Accelerated clearance of SHIV in rhesus monkeys by virus-like particle vaccines is dependent on induction of neutralizing antibodies.
Vaccine 1999;18(3-4):291-301.
1999: Christina Paulus; S Hellebrand; Uwe Tessmer; Hans Wolf; Hans-Georg Kräusslich; Ralf Wagner
Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein.
The Journal of biological chemistry 1999;274(31):21539-43.
1999: A Hengerer; C Kösslinger; Jochen Decker; S Hauck; Iris Queitsch; Hans Wolf; Stefan Dübel
Determination of phage antibody affinities to antigen by a microbalance sensor system.
BioTechniques 1999;26(5):956-60, 962, 964.
1999: Ralf Wagner; Y Shao; Hans Wolf
Correlates of protection, antigen delivery and molecular epidemiology: basics for designing an HIV vaccine.
Vaccine 1999;17(13-14):1706-10.
1999: Ralf Wagner; Bernd Leschonsky; Ellen G Harrer; Christina Paulus; C Weber; B D Walker; S Buchbinder; Hans Wolf; Joachim R Kalden; Thomas Harrer
Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(6):3727-34.
1999: Ludwig Deml; Reinhold Schirmbeck; J Reimann; Hans Wolf; Ralf Wagner
Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins.
Clinical chemistry and laboratory medicine : CCLM / FESCC 1999;37(3):199-204.
1999: Frank Notka; C Stahl-Hennig; U Dittmer; Hans Wolf; Ralf Wagner
Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model.
Biological chemistry 1999;380(3):341-52.
1999: A Hemauer; A Gigler; R Gareus; A Reichle; Hans Wolf; Susanne Modrow
Infection of apheresis cells by parvovirus B19.
The Journal of general virology 1999;80 ( Pt 3)():627-30.
1999: A Gigler; Simone Dorsch; A Hemauer; C Williams; S Kim; N S Young; Susan Zolla-Pazner; Hans Wolf; M K Gorny; Susanne Modrow
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.
Journal of virology 1999;73(3):1974-9.
1999: A Hengerer; Jochen Decker; Elke Prohaska; S Hauck; C Kösslinger; Hans Wolf
Quartz crystal microbalance (QCM) as a device for the screening of phage libraries.
Biosensors & bioelectronics 1999;14(2):139-44.
1999: Michael Nevels; B Täuber; Elisabeth Kremmer; Thilo Spruss; Hans Wolf; Thomas Dobner
Transforming potential of the adenovirus type 5 E4orf3 protein.
Journal of virology 1999;73(2):1591-600.
1999: Michael Nevels; Thilo Spruss; Hans Wolf; Thomas Dobner
The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Oncogene 1999;18(1):9-17.
1999: Michael Nevels; Hans Wolf; Thomas Dobner
Quantitation of beta-galactosidase from yeast cells using a chemiluminescent substrate.
BioTechniques 1999;26(1):57-8.
1998: N Greifenegger; M Jäger; L A Kunz-Schughart; Hans Wolf; Fritz Schwarzmann
Epstein-Barr virus small RNA (EBER) genes: differential regulation during lytic viral replication.
Journal of virology 1998;72(11):9323-8.
1998: S Pepperl; G Benninger-Döring; Susanne Modrow; Hans Wolf; Wolfgang Jilg
Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.
Journal of virology 1998;72(11):8644-9.
1998: Udo Reischl; Norbert Lehn; Hans Wolf; Ludmila Naumann
Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens.
Journal of clinical microbiology 1998;36(10):2853-60.
1998: S Gabler; H Schütt; Peter Groitl; Hans Wolf; Thomas Shenk; Thomas Dobner
E1B 55-kilodalton-associated protein: a cellular protein with RNA-binding activity implicated in nucleocytoplasmic transport of adenovirus and cellular mRNAs.
Journal of virology 1998;72(10):7960-71.
1998: Fritz Schwarzmann; M Jäger; Mathias W Hornef; NS Prang; Hans Wolf
Epstein-Barr viral gene expression in B-lymphocytes.
Leukemia & lymphoma 1998;30(1-2):123-9.
1998: M Jäger; G Benninger-Döring; NS Prang; B S Sylla; Barbara Laumbacher; Rudolf Wank; Hans Wolf; Fritz Schwarzmann
Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
International journal of cancer. Journal international du cancer 1998;76(5):694-701.
1998: M Vogel; K Wittmann; Elmar Endl; G Glaser; Ruth Knüchel; Hans Wolf; Hans Helmut Niller
Plasmid maintenance assay based on green fluorescent protein and FACS of mammalian cells.
BioTechniques 1998;24(4):540-2, 544.
1998: M Graf; Y Shao; Q Zhao; T Seidl; J Köstler; Hans Wolf; Ralf Wagner
Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China.
AIDS research and human retroviruses 1998;14(3):285-8.
1998: G Glaser; M Vogel; Hans Wolf; Hans Helmut Niller
Regulation of the Epstein-Barr viral immediate early BRLF1 promoter through a distal NF1 site.
Archives of virology 1998;143(10):1967-83.
1998: Fritz Schwarzmann; M Jäger; NS Prang; Hans Wolf
The control of lytic replication of Epstein-Barr virus in B lymphocytes (Review).
International journal of molecular medicine 1998;1(1):137-42.
1998: R Gareus; A Gigler; A Hemauer; M Leruez-Ville; Frédéric Morinet; Hans Wolf; Susanne Modrow
Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19.
Journal of virology 1998;72(1):609-16.
1997: B Kattenbeck; A von Poblotzki; A Rohrhofer; Hans Wolf; Susanne Modrow
Inhibition of human immunodeficiency virus type 1 particle formation by alterations of defined amino acids within the C terminus of the capsid protein.
The Journal of general virology 1997;78 ( Pt 10)():2489-96.
1997: Ludwig Deml; Reinhold Schirmbeck; J Reimann; Hans Wolf; Ralf Wagner
Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Virology 1997;235(1):26-39.
1997: Ludwig Deml; G Kratochwil; N Osterrieder; Ruth Knüchel; Hans Wolf; Ralf Wagner
Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
Virology 1997;235(1):10-25.
1997: NS Prang; Mathias W Hornef; M Jäger; H J Wagner; Hans Wolf; Fritz Schwarzmann
Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state.
Blood 1997;89(5):1665-77.
1997: Michael Nevels; S Rubenwolf; Thilo Spruss; Hans Wolf; Thomas Dobner
The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(4):1206-11.
1997: S Rubenwolf; H Schütt; Michael Nevels; Hans Wolf; Thomas Dobner
Structural analysis of the adenovirus type 5 E1B 55-kilodalton-E4orf6 protein complex.
Journal of virology 1997;71(2):1115-23.
1996: M Jäger; NS Prang; Manfred Mitterer; Clara Larcher; Hartwig P Huemer; Udo Reischl; Hans Wolf; Fritz Schwarzmann
Pathogenesis of chronic Epstein-Barr virus infection: detection of a virus strain with a high rate of lytic replication.
British journal of haematology 1996;95(4):626-36.
1996: A von Poblotzki; C Gerdes; Udo Reischl; Hans Wolf; Susanne Modrow
Lymphoproliferative responses after infection with human parvovirus B19.
Journal of virology 1996;70(10):7327-30.
1996: A Hemauer; A von Poblotzki; A Gigler; Pascal Cassinotti; Gunter Siegl; Hans Wolf; Susanne Modrow
Sequence variability among different parvovirus B19 isolates.
The Journal of general virology 1996;77 ( Pt 8)():1781-5.
1996: W Haedicke; Hans Wolf; W Ehret; Udo Reischl
Specific and sensitive two-step polymerase chain reaction assay for the detection of Salmonella species.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(7):603-7.
1996: R Wagner; Ludwig Deml; Reinhold Schirmbeck; Matthias Niedrig; Jörg Reimann; Hans Wolf
Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles.
Virology 1996;220(1):128-40.
1996: Udo Reischl; C Gerdes; M Motz; Hans Wolf
Expression and purification of an Epstein-Barr virus encoded 23-kDa protein and characterization of its immunological properties.
Journal of virological methods 1996;57(1):71-85.
1996: R Wagner; Ludwig Deml; Frank Notka; Hans Wolf; Reinhold Schirmbeck; Jörg Reimann; Vera J P Teeuwsen; Jonathan Luke Heeney
Safety and immunogenicity of recombinant human immunodeficiency virus-like particles in rodents and rhesus macaques.
Intervirology 1996;39(1-2):93-103.
1996: B Kattenbeck; A Rohrhofer; Matthias Niedrig; Hans Wolf; Susanne Modrow
Defined amino acids in the gag proteins of human immunodeficiency virus type 1 are functionally active during virus assembly.
Intervirology 1996;39(1-2):32-9.
1996: R Wagner; Ludwig Deml; Vera J P Teeuwsen; Jonathan Luke Heeney; S Yiming; Hans Wolf
A recombinant HIV-1 virus-like particle vaccine: from concepts to a field study.
Antibiotics and chemotherapy 1996;48():68-83.
1995: A von Poblotzki; A Hemauer; A Gigler; Elisabeth Puchhammer-Stöckl; Franz X Heinz; Jörg Pont; Klaus Laczika; Hans Wolf; Susanne Modrow
Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.
The Journal of infectious diseases 1995;172(5):1356-9.
1995: C Bogedain; Hans Wolf; Susanne Modrow; G Stuber; Wolfgang Jilg
Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus.
Journal of virology 1995;69(8):4872-9.
1995: H J Linde; A Hengerer; E Voggesberger; J Hecht; W Ehret; Hans Wolf
[Eradication of Legionella from warm water systems--documentation of our own experiences with thermal disinfection].
Zentralblatt für Hygiene und Umweltmedizin = International journal of hygiene and environmental medicine 1995;197(5):441-51.
1995: Reinhold Schirmbeck; Ludwig Deml; K Melber; Hans Wolf; R Wagner; Jörg Reimann
Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens.
Vaccine 1995;13(9):857-65.
1995: Hans Helmut Niller; G Glaser; Ruth Knüchel; Hans Wolf
Nucleoprotein complexes and DNA 5'-ends at oriP of Epstein-Barr virus.
The Journal of biological chemistry 1995;270(21):12864-8.
1995: R Wagner; J Mayer; Hans Wolf
[Current advances in HIV pathogenesis. Results of therapy and vaccine development].
Deutsche medizinische Wochenschrift (1946) 1995;120(20):728-36.
1995: Nikolaus Osterrieder; R Wagner; Christine Brandmüller; P Schmidt; Hans Wolf; Oskar-Rüger Kaaden
Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
Virology 1995;208(2):500-10.
1995: NS Prang; Hans Wolf; Fritz Schwarzmann
Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1.
Journal of virology 1995;69(4):2644-8.
1995: G Stuber; Joakim Dillner; Susanne Modrow; Hans Wolf; L Székely; George Klein; Eva Klein
HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
International immunology 1995;7(4):653-63.
1995: H C Borbe; G Stuber; R Wagner; Hans Wolf; Susanne Modrow
Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Journal of peptide science : an official publication of the European Peptide Society 1995;1(2):109-23.
1995: A von Poblotzki; A Gigler; B Lang; Hans Wolf; Susanne Modrow
Antibodies to parvovirus B19 NS-1 protein in infected individuals.
The Journal of general virology 1995;76 ( Pt 3)():519-27.
1995: J Huber; W Hell; Hans Wolf
A non-radioactive multiprime sequencing method for HIV genomes.
Journal of virological methods 1995;51(2-3):259-66.
1995: S Y Gu; T M Huang; L Ruan; Y H Miao; H Lu; C M Chu; M Motz; Hans Wolf
First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen.
Developments in biological standardization 1995;84():171-7.
1994: R Wagner; Ludwig Deml; Reinhold Schirmbeck; Jörg Reimann; Hans Wolf
Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
Behring Institute Mitteilungen 1994;(95):23-34.
1994: Udo Reischl; M Pulz; W Ehret; Hans Wolf
PCR-based detection of mycobacteria in sputum samples using a simple and reliable DNA extraction protocol.
BioTechniques 1994;17(5):844-5.
1994: Susanne Modrow; B Kattenbeck; A von Poblotzki; Matthias Niedrig; R Wagner; Hans Wolf
The gag proteins of human immunodeficiency virus type 1: mechanisms of virus assembly and possibilities for interference.
Medical microbiology and immunology 1994;183(4):177-94.
1994: Fritz Schwarzmann; NS Prang; B Reichelt; B Rinkes; S Haist; M Marschall; Hans Wolf
Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1.
The Journal of general virology 1994;75 ( Pt 8)():1999-2006.
1994: Wolfgang Jilg; C Bogedain; H Mairhofer; S Y Gu; Hans Wolf
The Epstein-Barr virus-encoded glycoprotein gp 110 (BALF 4) can serve as a target for antibody-dependent cell-mediated cytotoxicity (ADCC).
Virology 1994;202(2):974-7.
1994: R Wagner; L Deml; H Fliessbach; G Wanner; Hans Wolf
Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
Virology 1994;200(1):162-75.
1994: G Stuber; G H Leder; W T Storkus; Michael T Lotze; Susanne Modrow; L Székely; Hans Wolf; Eva Klein; Klas Kärre; George Klein
Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay.
European journal of immunology 1994;24(3):765-8.
1994: C Bogedain; P Alliger; Fritz Schwarzmann; M Marschall; Hans Wolf; Wolfgang Jilg
Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell lines.
Journal of virology 1994;68(2):1200-3.
1993: R Wagner; T Böltz; Ludwig Deml; Susanne Modrow; Hans Wolf
Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
The Journal of general virology 1993;74 ( Pt 7)():1261-9.
1993: A von Poblotzki; R Wagner; Matthias Niedrig; G Wanner; Hans Wolf; Susanne Modrow
Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation.
Virology 1993;193(2):981-5.
1993: Hans Helmut Niller; Hans Wolf
[Epstein-Barr virus].
Zentralblatt für Hygiene und Umweltmedizin = International journal of hygiene and environmental medicine 1993;194(1-2):118-25.
1993: Hans Wolf; C Bogedain; Fritz Schwarzmann
Epstein-Barr virus and its interaction with the host.
Intervirology 1993;35(1-4):26-39.
1993: M Marschall; P Alliger; Fritz Schwarzmann; C Bogedain; M Brand; B Reichelt; G Glaser; Hans Wolf
The lytic transition of Epstein-Barr virus is imitated by recombinant B-cells.
Archives of virology 1993;129(1-4):23-33.
1992: S Haist; J März; Hans Wolf; Susanne Modrow
Reactivities of HIV-1 gag-derived peptides with antibodies of HIV-1-infected and uninfected humans.
AIDS research and human retroviruses 1992;8(11):1909-17.
1992: J Bujía; Andreas Riederer; Christian Zietz; E Wilmes; Hans Wolf
[Oral hairy leukoplakia in human immunodeficiency virus positive patients: clinical and etiopathogenic aspects].
Acta otorrinolaringológica española 1992;43(6):413-7.
1992: G Stuber; Susanne Modrow; Petter Höglund; L Franksson; J Elvin; Hans Wolf; Klas Kärre; George Klein
Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells.
European journal of immunology 1992;22(10):2697-703.
1992: J Bujía; E Wilmes; Hans Wolf; J Bartual
[The presence of the Epstein-Barr virus in Waldeyer's lymphatic ring during the acute phase of infectious mononucleosis].
Acta otorrinolaringológica española 1992;43(2):93-6.
1992: A Langford; Rudolf Kunze; S Schmelzer; Hans Wolf; HD Pohle; P Reichart
Immunocytochemical detection of herpes viruses in oral smears of HIV-infected patients.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1992;21(2):49-57.
1992: R Wagner; Susanne Modrow; T Böltz; H Fliessbach; Matthias Niedrig; Albrecht von Brunn; Hans Wolf
Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3.
Archives of virology 1992;127(1-4):139-52.
1992: R Wagner; H Fliessbach; G Wanner; M Motz; Matthias Niedrig; G Deby; Albrecht von Brunn; Hans Wolf
Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
Archives of virology 1992;127(1-4):117-37.
1992: Susanne Modrow; B Höflacher; Hans Wolf
Identification of a protein encoded in the EB-viral open reading frame BMRF2.
Archives of virology 1992;127(1-4):379-86.
1991: Shuyan Gu; T Huang; Y Miao; L Ruan; Y Zhao; C Han; Y Xiao; J Zhu; Hans Wolf
A preliminary study on the immunogenicity in rabbits and in human volunteers of a recombinant vaccinia virus expressing Epstein-Barr virus membrane antigen.
Chinese medical sciences journal = Chung-kuo i hsüeh k'o hsüeh tsa chih / Chinese Academy of Medical Sciences 1991;6(4):241-3.
1991: J Becker; U Leser; M Marschall; A Langford; Wolfgang Jilg; H Gelderblom; P Reichart; Hans Wolf
Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(19):8332-6.
1991: M Marschall; Fritz Schwarzmann; U Leser; B Oker; P Alliger; H Mairhofer; Hans Wolf
The BI'LF4 trans-activator of Epstein-Barr virus is modulated by type and differentiation of the host cell.
Virology 1991;181(1):172-9.
1991: T F Schwarz; Susanne Modrow; B Hottenträger; B Höflacher; Gabriele Jäger; W Scharti; R Sumazakl; Hans Wolf; Jaap Middeldorp; Michael Roggendorf
New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies.
Journal of clinical microbiology 1991;29(3):431-5.
1991: W Jilg; R Voltz; C Markert-Hahn; H Mairhofer; I Münz; Hans Wolf
Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells.
Cancer research 1991;51(1):27-32.
1990: W Jilg; E Sieger; P Alliger; Hans Wolf
Identification of type A and B isolates of Epstein-Barr virus by polymerase chain reaction.
Journal of virological methods 1990;30(3):319-22.
1990: U Schumacher; J Eberle; Hans Wolf; U Welsch; H W Ziegler-Heitbrook; Lutz Gürtler; F Deinhardt
Carbohydrate components of human immunodeficiency viruses type I and II.
Acta histochemica. Supplementband 1990;40():85-9.
1989: M Marschall; M Motz; U Leser; Fritz Schwarzmann; B Oker; Hans Wolf
Hepatitis B virus surface antigen as a reporter of promoter activity.
Gene 1989;81(1):109-17.
1989: Peter A Reichart; A Langford; H R Gelderblom; HD Pohle; J Becker; Hans Wolf
Oral hairy leukoplakia: observations in 95 cases and review of the literature.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1989;18(7):410-5.
1989: R Sumazaki; M Motz; Hans Wolf; J Heinig; W Jilg; F Deinhardt
Detection of hepatitis B virus in serum using amplification of viral DNA by means of the polymerase chain reaction.
Journal of medical virology 1989;27(4):304-8.
1989: Susanne Modrow; B Höflacher; R Mertz; Hans Wolf
Carrier-bound synthetic peptides. Use as antigen in HIV-1 ELISA tests and in antiserum production.
Journal of immunological methods 1989;118(1):1-7.
1989: M Marschall; U Leser; R Seibl; Hans Wolf
Identification of proteins encoded by Epstein-Barr virus trans-activator genes.
Journal of virology 1989;63(2):938-42.
1989: R Voltz; W Jilg; Hans Wolf
Modification of HLA expression as a possible factor in the pathogenesis of Burkitt's lymphoma.
Haematology and blood transfusion 1989;32():289-92.
1989: Susanne Modrow; B Höflacher; W Mellert; Volker Erfle; B Wahren; Hans Wolf
Use of synthetic oligopeptides in identification and characterization of immunological functions in the amino acid sequence of the envelope protein of HIV-1.
Journal of acquired immune deficiency syndromes 1989;2(1):21-7.
1989: E Wilmes; Hans Wolf
[Epstein-Barr virus infections. New pathogenic and clinical aspects].
Laryngo- rhino- otologie 1989;68(1):36-43.
1989: Susanne Modrow; B Höflacher; Lutz Gürtler; F Deinhardt; Hans Wolf
Carrier bound synthetic oligopeptides in ELISA test systems for distinction between HIV-1 and HIV-2 infection.
Journal of acquired immune deficiency syndromes 1989;2(2):141-8.
1988: HH Gerhartz; J Mittermüller; A Raghavachar; Helga Schmetzer; C Clemm; Hans-Jochem Kolb; C C Bartram; Hans Wolf
Epstein-Barr virus-positive recipient type B-cells survive in a "complete chimera" after allogeneic bone-marrow transplantation.
International journal of cancer. Journal international du cancer 1988;42(5):672-6.
1988: Hans Wolf; S Modrow; M Motz; B A Jameson; G Hermann; B Förtsch
An integrated family of amino acid sequence analysis programs.
Computer applications in the biosciences : CABIOS 1988;4(1):187-91.
1987: N Falser; I Bandtlow; H J Rziha; M Haus; Hans Wolf
The role of acute and latent virus infections in the pathogenesis of inner ear disturbances.
The American journal of otology 1987;8(2):136-47.
1987: M Motz; G Deby; Hans Wolf
Truncated versions of the two major Epstein-Barr viral glycoproteins (gp250/350) are secreted by recombinant Chinese hamster ovary cells.
Gene 1987;58(1):149-54.
1986: R Seibl; M Motz; Hans Wolf
Strain-specific transcription and translation of the BamHI Z area of Epstein-Barr Virus.
Journal of virology 1986;60(3):902-9.
1986: Hans Wolf; U Leser; M Haus; S Y Gu; R Pathmanathan
Sandwich nucleic acid hybridization: a method with a universally usable labeled probe for various specific tests.
Journal of virological methods 1986;13(1):1-8.
1986: M Motz; G Deby; W Jilg; Hans Wolf
Expression of the Epstein-Barr virus major membrane proteins in Chinese hamster ovary cells.
Gene 1986;44(2-3):353-9.
1986: N Falser; I Bandtlow; M Haus; Hans Wolf
Demonstration of pseudorabies virus DNA in the mouse inner ear by an in situ nucleic acid hybridization technique in plastic embedded bony material.
Journal of microscopy 1986;141(Pt 1):55-67.
1986: N Falser; I Bandtlow; M Haus; Hans Wolf
Detection of pseudorabies virus DNA in the inner ear of intranasally infected BALB/c mice with nucleic acid hybridization in situ.
Journal of virology 1986;57(1):335-9.
1986: M Motz; J Fan; R Seibl; W Jilg; Hans Wolf
Expression of the Epstein-Barr virus 138-kDa early protein in Escherichia coli for the use as antigen in diagnostic tests.
Gene 1986;42(3):303-12.